India - Omicron: Scientists issue warning US reports firs...| MENAFN.COM

Wednesday, 28 September 2022 07:01 GMT

India - Omicron: Scientists issue warning US reports first case

(MENAFN- NewsBytes)

Omicron is a new strain of coronavirus most prevalent in South Africa. Meanwhile, the variant has spread to more countries including the United States and South Korea. Here are more details on this.

Details Virus has mostly affected young people so far: Experts

The actual impact of Omicron is hard to determine at this point because it has so far mostly affected young people who generally have stronger immunity, scientists said. Further, people tend to become sicker after carrying the virus for some time, the experts told lawmakers on Wednesday. 'We are also expecting that the more severe complications may not present themselves for a few weeks.'

Quote 'It can still find vulnerable people'

'If this virus and this variant spreads very efficiently through the population, then it will still be able to find those people in the population who are unvaccinated and may be unprotected against severe disease,' Richard Lessells of the KRISP genomics institute said. 'That's what also concerns us when we think about the continent more generally.'

Spread US, other countries report first cases

The US has confirmed its first case of Omicron. The infected person had returned from South Africa on November 22 and tested positive on November 29. They were fully vaccinated but did not receive any booster dose. The World Health Organisation (WHO) said the strain has reached 23 nations including Nigeria, South Korea, Portugal, and Sweden, among others.

Strain What do we know about Omicron?

Omicron—whose scientific name is B.1.1.529—has some 50 mutations including more than 30 in its key spike protein alone. The strain may be more transmissible, however, more studies are required to establish the same. Symptoms in people carrying the variant in South Africa were said to be 'mild.' Studies are on to determine the efficacy of existing COVID-19 tests, vaccines, and treatment against Omicron.

Share this timeline


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.